It has already been established that hepatocyte transplantation (HTx) in animal models, such as both chemically and surgically induced acute liver failure, liver-based metabolic disease, and cirrhosis, resulted in significant improvement of liver function and survival. However, the efficacy of hepatocyte transplantation in secondary cholestatic liver disease is not well known. In this study, we transplanted hepatocytes into the spleen of Nagase analbuminemic rats (NARs) with common bile duct ligation (CBDL) to evaluate the function of transplanted hepatocytes by both of serum albumin levels and total bilirubin levels. CBDL was carried out on NARs to induce liver failure. Lewis rat hepatocytes were transplanted in NARs 7 days after CBDL. Animals, in groups of four, underwent the following interventions: group 1-intrasplenic transplantation of 30 × 10 6 primary Lewis rat hepatocytes in NARs with CBDL (n = 4), group 2-intrasplenic injection of 0.5 ml DMEM in NARs with CBDL (n = 4); group 3-CBDL only (n = 4); group 4-intrasplenic transplantation of 30 × 10 6 primary Lewis rat hepatocytes in NARs (n = 4). Both bilirubin levels and albumin levels in NARs with CBDL were significantly improved post-HTx. Animals receiving hepatocyte transplantation survived longer than animals in nontransplant control groups. This study indicates that hepatocytes can be transplanted to temporarily provide life-supporting liver-specific metabolic function and prolong the survival in recipient rats with liver failure induced by CBDL. 547 548 ITO ET AL.
INTRODUCTION
trasplenic hepatocyte transplantation on hepatic encephalopathy in an experimental model of chronic liver failure induced by a portocaval shunt in the rat was Hepatocyte transplantation has been investigated in animal models of liver failure for more than 30 years evaluated. Transplanted hepatocytes cannot migrate to the liver; however, they are engrafted in the spleen. He-and demonstrated significant improvement of the survival of animals with both chemically and surgically in-patocyte transplantation in the spleen of these rats improved spontaneous activity and neurologic reflexes and duced acute liver failure (6) . Furthermore, studies in animals with hereditary liver disorders have provided the partially corrected their amino acid imbalances (14) . Intrasplenic hepatocyte transplantation has been indicated knowledge about the function of transplanted hepatocytes. Animal models of liver-based metabolic disease, to be effective in rats with decompensated liver cirrhosis induced with carbon tetrachloride and phenobarbital. such as the fumarylacetoacetate hydrolase (FAH)-deficient mouse, which is a model for hereditary tyrosinemia
The indicators of estimating liver function, such as serum albumin, prothrombin time, total bilirubin, serum type I (13), the Gunn rat, which is a model for human Crigler-Najjar syndrome type I (11) , and the Long-ammonia, and hepatic encephalopathy score, are improved in all points, and survival is significantly pro-Evans Cinnamon (LEC) rat, which is a model of Wilson's disease (19) , have been used to prove that hepato-longed compared with nontransplanted rats. In these studies, hepatocyte transplantation normalized liver cyte transplantation has the potential of normalizing metabolic disorders. In another study, the effect of in-function and improved survival (8). Common bile duct ligation (CBDL) in rats is a model approved by the Fujita health University Institutional Animal Care. for cholestatic liver disease and secondary biliary cirrhosis (1, 7, 10, 15, 18) . To investigate the efficacy of hepatocyte transplantation on secondary cholestatic liver dis-
Isolation of Hepatocytes ease, and the function of transplanted cells by both
Hepatocytes from Lewis rats were isolated by in situ serum albumin levels and total bilirubin levels, Nagase two-step collagenase (type IV, Sigma Chemical Co., St. analbuminemic rats (NARs) treated with CBDL were Louis, MO) perfusion technique introduced by Berry used for this experiment. and Friend (3) and modified by Seglen (16) . Cell viability was consistently between 85% and 90%, as deter-MATERIALS AND METHODS mined by trypan blue exclusion. Animals Inbred male Lewis rats (150-250 g) and NARs (100-Common Bile Duct Ligation (CBDL) 250 g) were obtained from Chubu-kagagu-shizai, Nagoya, Japan and maintained in the Animal Resource Fa-Bile duct ligation was carried out on NARs under anesthesia with Isoflurane inhalation. The common bile cility of the Fujita-Health University. All animals were maintained on standard laboratory chow diet on a 12-h duct was exposed by median laparotomy and doubleligated with silk suture. The segment between the liga-light/dark cycle. All procedures performed on rats were tures was cut completely to prevent recanalization Serum Albumin Levels and Total Bilirubin Levels (1, 7, 10, 15 ).
Blood samples were obtained from the tail vein at various time points. Serum albumin levels were mea-Hepatocyte Transplantation (HTx) sured by a turbidimetric immunoassey and total bilirubin Seven days after CBDL, NARs were anesthetized levels were measured by a peroxidase-catalyzed oxidawith Isoflurane inhalation, and the spleen was exposed tion assay. by a left flank incision. Thirty million hepatocytes, suspended in 0.5 ml of Dulbecco's modified Eagle medium Statistics (DMEM), were injected into the inferior pole of the spleen using a 25-gauge needle connected to a tubercu-Values are expressed as mean ± SE. Statistical differlin syringe. The blood flow in the splenic artery and vein ences were determined as noted in the text. Life-table was occluded for approximately 5 min to avoid immedianalysis was performed using the Kaplan-Meier plot and ate passage of cells into the portal vein during transplan-Logrank (Mantel-Cox) analysis. tation. The injection site was ligated to prevent cell leakage and bleeding using 3-0 silk suture. Sham operation, RESULTS involving intrasplenic injection of 0.5 ml DMEM and Induction of Liver Failure by CBDL clamping of the splenic vein and artery for 5 min, was performed in NARs. The animals that were transplanted
To investigate the effect of allogeneic hepatocyte transplantation in rats with liver failure led by bile duct with hepatocytes and injected with DMEM received intramuscular injections of 1 mg/kg/day FK506 (Tacrol-obstruction, we used NARs treated with CBDL as a model of obstructive jaundice. Seven days after CBDL, imus;Astellas) every other day to suppress immune rejection of allogeneic transplanted hepatocytes (2-3,4, the total bilirubin levels were reached to approximately 1.0 mg/dl and the common bile duct was dilated as 12,15,17). After death, the spleen and liver specimens were fixed in 10% neutral buffered formalin. Serial sec-shown in Figure 1A . The NARs died on 12.8 ± 3.6 days after CBDL and the liver was removed for histological tions of the paraffin-embedded tissue sections were cut and stained with hematoxylin and eosin.
examination. As shown in Figure 1B -D, there were many clusters of necrotic hepatocytes and bile duct epi-operation; p < 0.001) ( Fig. 3 ). By postoperative day 42, the levels of albumin in NARs treated with CBDL and thelial cells proliferated in the portal tract.
HTx gradually decreased to pretransplant values (group Hepatocyte Transplantation in NARs 1: 1.15 mg/dl). In contrast, the albumin levels in the With Liver Failure positive control group (hepatocyte transplantation without CBDL) were well maintained at approximately 18 To address whether hepatocyte transplantion can rescue rats from hepatic failure and death, Lewis rat hepa-mg/ml ( Fig. 3 ). Animals receiving hepatocyte transplantation survived significantly longer than animals in the tocytes were transplanted in NARs 7 days after CBDL. Animals underwent the following interventions: group nontransplant control groups (group 1: 35 ± 4.2 days; groups 2 and 3: 12.1 ± 4.9 days; p < 0.01) ( Fig. 4 ). 1-intrasplenic transplantation of 30 × 10 6 primary Lewis rat hepatocytes in NARs with CBDL (n = 4);
Histological studies showed that a large mass of mature hepatocytes existed in the spleens of transplanted group 2-intrasplenic injection of 0.5 ml DMEM in NARs with CBDL (n = 4); group 3-CBDL only (n = rats 5 days ( Fig. 5A ) and 7 days (Fig. 5B ) after HTx. At the time of death, bilirubin accumulated inside and 4); group 4-intrasplenic transplantation of 30 × 10 6 primary Lewis rat hepatocytes in NARs (n = 4). As shown around hepatocytes, and a large proportion of the hepatocytes exhibited eosinophilic cytoplasm and condensed in Figure 2 , rats receiving intrasplenic hepatocyte transplantation were protected from the development of hy-or fragmented nuclei, characteristic of cells at various stages of apoptosis (Fig. 5C, D) . At this time, there were per-bilirubinemia compared to control animals (group 1: 0.45 ± 0.25 mg/dl; group 2: 2.2 ± 0.2 mg/dl; group 3: extensive necrotic areas in the liver. 2.12 ± 0.37 mg/dl; 1 week after HTx or sham operation; DISCUSSION p < 0.001; ANOVA pairwise multiple comparison by Tukey method). Serum albumin levels were significant Investigators used the common bile duct ligation model for the study of chronic liver failure using ordi-different between the groups with and without HTx (group 1: 17.4 ± 0.3 mg/dl; group 2: 2.1 ± 0.5 mg/dl; nary rats. The animals revealed cirrhosis after 4 weeks of the CBDL and died 31 days after the operation (1). group 3: 2.22 ± 0.2 mg/dl; 1 week after HTx or sham Because we assess the function of transplanted cells by ment of donor cells and hepatic cord-like structures (5, 9, 19) . However, even the spleen is inefficient in sup-both serum albumin levels and total bilirubin levels, the NARs treated with CBDL were used for this experiment.
porting long-term viability of liver cells. In this study, histological examination shows that the bile secreted by The rats died on 12.8 ± 3.6 days after the procedure. In order to ascertain whether the early death was caused by the transplanted hepatocytes causes trouble in the spleen owing to the absence of a bile drainage system. The fail-the technical matter of CBDL procedure or the property of NARs, we performed CBDL on normal Lewis rats.
ure of bile discharge does not occur when hepatocytes are transplanted into the liver, because they migrate to These rats died on 34.4 ± 5.6 after the operation. This result indicates that the combination of NARs and liver parenchyma and their secretory products have access to the bile ducts. However, in the case of common CBDL shortens the survival of the rats.
Furthermore, this study shows that intrasplenic hepa-bile duct ligation, the bile secreted by hepatocytes in the spleen is unable to go through the bile duct, so it tocyte transplantation in NARs with hepatic failure induced by CBDL can improve total bilirubin levels and consequently accumulates in the spleen and eventually the high level of bile precipitated transplanted hepato-albumin levels, and also prolong the survival. However, the albumin levels deteriorated gradually and returned cyte death. Therefore, in this case, hepatocyte infusion may offer transient function for life support and gain to pretransplant values by 1 month after transplantation. The total bilirubin levels, increased by CBDL, were im-time for orthotopic liver transplantation.
In summary, the data presented here demonstrate that proved by transplantation, but they finally rose to approximately 1.5 mg/dl on 35 days after transplantation.
hepatocytes can be transplanted to temporarily provide life-supporting liver-specific metabolic function and In histological experiments, accumulation of bilirubin was found inside and around transplanted hepatocytes prolong the survival in recipients rats with liver failure induced by CBDL. and eventually precipitated the death of the cells.
The spleen is one of the best sites for hepatocyte en- tion in laboratory studies indicated excellent engraft- 
